FOLFOX regimen plus dendritic cells–cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis

References

• ChenYXYangQKuangJJEfficacy of adding bevacizumab in the first-line chemotherapy of metastatic colorectal cancer: evidence from seven randomized clinical trialsGastroenterol Res Pract2014201418
   Google Scholar
• GevaRVecchioneLTejparSPiessevauxHVan CutsemEPrenenHBevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancerOnco Targets Ther20136535823378775
   PubMed Web of Science ®Google Scholar
• KimJSKimYGParkEJCell-based immunotherapy for colorectal cancer with cytokine-induced killer cellsImmune Netw20161629910827162526
   PubMedGoogle Scholar
• GuoYXiongBHZhangTChengYMaLXELOX vs. FOLFOX in metastatic colorectal cancer: an updated meta-analysisCancer Invest20163429410426864862
   PubMed Web of Science ®Google Scholar
• ColucciGGebbiaVPaolettiGPhase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia MeridionaleJ Clin Oncol200523224866487515939922
   PubMed Web of Science ®Google Scholar
• MuYZhouCHChenSFEffectiveness and safety of chemotherapy combined with cytokine-induced killer cell/dendritic cell-cytokine- induced killer cell therapy for treatment of gastric cancer in China: a systematic review and meta-analysisCytotherapy20161891162117727421742
   PubMedGoogle Scholar
• MuYWangWHXieJPZhangYXYangYPZhouCHEfficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II studyOnco Targets Ther201694617462727524915
   PubMed Web of Science ®Google Scholar
• ZhouCLLiuDLLiJChemotherapy plus dendritic cells co-cultured with cytokine-induced killer cells versus chemotherapy alone to treat advanced non-small-cell lung cancer: a meta-analysisOncotarget2016752865008651027863436
   PubMedGoogle Scholar
• ZhaoZLiaoHJuYEffect of compound Kushen injection on T-cell subgroups and natural killer cells in patients with locally advanced non-small-cell lung cancer treated with concomitant radiochemotherapyJ Tradit Chin Med2016361141826946613
   PubMedGoogle Scholar
• DudleyMEGrossCASomervilleRPRandomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanomaJ Clin Oncol201331172152215923650429
   PubMed Web of Science ®Google Scholar
• ChiaWKTeoMWangWWAdoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaMol Ther201422113213924297049
   PubMed Web of Science ®Google Scholar
• ArteneSATurcu-StiolicaAHartleyRDendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysisOnco Targets Ther201696669667727877052
   PubMed Web of Science ®Google Scholar
• JakelCESchmidt-WolfIGAn update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cellsExpert Opin Biol Ther201414790591624673175
   PubMed Web of Science ®Google Scholar
• ZhongRHanBZhongHA prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patientsTumour Biol201435298799424006222
   PubMedGoogle Scholar
• WeiXCYangDDHanXRBioactivity of umbilical cord blood dendritic cells and anti-leukemia effectInt J Clin Exp Med2015810197251973026770637
   PubMed Web of Science ®Google Scholar
• LiHRenXB,ZhangPAnXMLiuHHaoXSDendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cellsZhonghua Yi Xue Za Zhi2005854431343138 Chinese [with English abstract]16405818
   PubMedGoogle Scholar
• SchmidtJEisoldSBuchlerMWMartenADendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinomaCancer Immunol Immunother200453111018102615185013
   PubMed Web of Science ®Google Scholar
• GeWLiCHZhangWCoculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo]Zhonghua Xue Ye Xue Za Zhi2004255277280 Chinese [with English abstract]15182535
   PubMedGoogle Scholar
• ZhaoHWangYYuJPAutologous cytokine-induced killer cells improves overall survival of metastatic colorectal cancer patients: results from a phase II clinical trialClin Colorectal Cancer201615322823527052743
   PubMed Web of Science ®Google Scholar
• LinTSongCChuoDYZhangHZhaoJClinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective studyTumour Biol20163744367437226499782
   PubMedGoogle Scholar
• GaoDLiCXieXAutologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patientsPLoS One201494e9388624699863
   PubMed Web of Science ®Google Scholar
• WangZXCaoJXLiuZPCombination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysisWorld J Gastroenterol2014204109524574784
   PubMedGoogle Scholar
• ZengXZhangYKwongJSThe methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic reviewJ Evid Based Med20158121025594108
   PubMedGoogle Scholar
• HanRXLiuXPanPJiaYJYuJCEffectiveness and safety of chemotherapy combined with dendritic cells co-cultured with cytokine-induced killer cells in the treatment of advanced non-small-cell lung cancer: a systematic review and meta-analysisPLoS One201499e10895825268709
   PubMed Web of Science ®Google Scholar
• JacksonDWhiteIRRileyRDQuantifying the impact of between-study heterogeneity in multivariate meta-analysesStat Med201231293805382022763950
   PubMed Web of Science ®Google Scholar
• BianJRStudy on chemotherapy combined with DC-CIK on colorectal cancerChin J Surg Oncol201355306309
   Google Scholar
• HouZYClinical study of DC-CIK combined with chemotherapy in the treatment of colon cancerGuide China Med201513356465
   Google Scholar
• LiSLiYLiangJLiuXLThe study of clinical application of DC-CIK combined with chemotherapy on colon cancerChin J Immunol2012289835839
   Google Scholar
• LiWWZhangHPWuMStudy on DC-CIK cells combined with intravenous chemotherapy for advanced colorectal cancer with diffuse hepatic metastasisMod J Integr Tradit Chin West Med2016251819421945
   Google Scholar
• RuiTWuGQXuJZhengAHWuHYeZYActivated DC combined with CIK immunotherapy for patients with advanced colorectal cancerZhejiang Med J20151815051509
   Google Scholar
• WangRYiMYangSRChaiLXHuaMThe influence of DC-CIK in advanced colorectal cancer patients on T lymphocyte subsets and cytokinesJ Hainan Med Univ2016221415801583
   Google Scholar
• WengHGShenDMaoWDHanLXClinical efficacy of DC-CIK immunotherapy combined with chemotherapy in treatment of advanced colorectal cancerZhejiang Med J20158626629
   Google Scholar
• WengJFYuLWLiYPShiYQPuYDCaoZYClinical observation of co-treatment with CIK cells and dendritic cells for advanced rectal cancerChin J Clin Oncol Rehabil201421910401043
   Google Scholar
• YuanJHPengDWLiJWWangMQClinical research of dendritic cells combined with cytokine induced killer cells therapy for advanced colorectal cancerChin Gen Pract20113641394141
   Google Scholar
• ZhouQMObservation effect of biological immune method in the treatment of patients with advanced colorectal cancerChina Mod Med201522343739
   Google Scholar
• LevyMVisokaiVLipskaLTopolcanOTumor markers in staging and prognosis of colorectal carcinomaNeoplasma200855213814218237252
   PubMedGoogle Scholar
• WangRFSongBRPengJJThe prognostic value of preoperative serum CEA and CA19-9 values in stage I–III colorectal cancerHepatogastroenterology20146113299499926158155
   PubMedGoogle Scholar
• YangXQChenCPengCWLiuSPLiYCarbohydrate antigen 242 highly consists with carbohydrate antigen 19-9 in diagnosis and prognosis of colorectal cancer: study on 185 casesMed Oncol20122921030103621553105
   PubMedGoogle Scholar
• ZhangSYLinMZhangHBDiagnostic value of carcinoembryonic antigen and carcinoma antigen 19-9 for colorectal carcinomaInt J Clin Exp Pathol2015889404940926464695
   PubMed Web of Science ®Google Scholar
• WangMCaoJXPanJHAdoptive immunotherapy of cytokine-induced killer cell therapy in the treatment of non-small cell lung cancerPLoS One2014911e11266225412106
   PubMed Web of Science ®Google Scholar
• LiuHLiJWangFComparative study of different procedures for the separation of peripheral blood mononuclear cells in cytokine-induced killer cell immunotherapy for hepatocarcinomaTumour Biol20153642299230725417201
   PubMedGoogle Scholar
• DulosJCarvenGJvan BoxtelSJPD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancerJ Immunother201235216917822306905
   PubMed Web of Science ®Google Scholar
• WangZXCaoJXWangMAdoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysisCytotherapy201416793494524794183
   PubMed Web of Science ®Google Scholar
• OliosoPGiancolaRDi RitiMContentoAAccorsiPIaconeAImmunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trialHematol Oncol200927313013919294626
   PubMed Web of Science ®Google Scholar
• LeeJHLimYSYeonJEAdjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinomaGastroenterology2015148713831391e625747273
   PubMed Web of Science ®Google Scholar
• LinnYCNiamMChuSThe anti-tumour activity of allogeneic cytokine-induced killer cells in patients who relapse after allogeneic transplant for haematological malignanciesBone Marrow Transplant201247795796621986635
   PubMed Web of Science ®Google Scholar
• Schmidt-WolfIGFinkeSTrojaneckBPhase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphomaBr J Cancer19998161009101610576658
   PubMed Web of Science ®Google Scholar